...
首页> 外文期刊>Journal of clinical nursing >Manuka honey vs. hydrogel--a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers.
【24h】

Manuka honey vs. hydrogel--a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers.

机译:麦卢卡蜂蜜与水凝胶-一项前瞻性,开放标签,多中心,随机对照试验,用于比较静脉溃疡的除淤功效和治愈结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Comparison of desloughing efficacy after four weeks and healing outcomes after 12 weeks in sloughy venous leg ulcers treated with Manuka honey (Woundcare 18+) vs. standard hydrogel therapy (IntraSite Gel). BACKGROUND: Expert opinion suggests that Manuka honey is effective as a desloughing agent but clinical evidence in the form of a randomised controlled trial is not available. There is a paucity of research which uses Manuka honey in venous ulcers. DESIGN: Prospective, multicentre, open label randomised controlled trial. METHOD: Randomisation was via remote telephone. One hundred and eight patients with venous leg ulcers having >or=50% wound area covered in slough, not taking antibiotics or immunosuppressant therapy were recruited from vascular centres, acute and community care hospitals and leg ulcer clinics. The efficacy of WoundCare 18+ to deslough the wounds after four weeks and its impact on healing after 12 weeks when compared with IntraSite Gel control was determined. Treatment was applied weekly for four weeks and follow-up was made at week 12. RESULTS: At week 4, mean % reduction in slough was 67% WoundCare 18+ vs. 52.9% IntraSite Gel (p = 0.054). Mean wound area covered in slough reduced to 29% and 43%, respectively (p = 0.065). Median reduction in wound size was 34% vs. 13% (p = 0.001). At 12 weeks, 44% vs. 33% healed (p = 0.037). Wounds having >50% reduction in slough had greater probability of healing at week 12 (95% confidence interval 1.12, 9.7; risk ratio 3.3; p = 0.029). Infection developed in 6 of the WoundCare 18+ group vs. 12 in the IntraSite Gel group. CONCLUSION: The WoundCare 18+ group had increased incidence of healing, effective desloughing and a lower incidence of infection than the control. Manuka honey has therapeutic value and further research is required to examine its use in other wound aetiologies. RELEVANCE TO CLINICAL PRACTICE: This study confirms that Manuka honey may be considered by clinicians for use in sloughy venous ulcers. Additionally, effective desloughing significantly improves healing outcomes.
机译:目的:对比使用麦卢卡蜂蜜(Woundcare 18+)和标准水凝胶疗法(IntraSite Gel)治疗的下肢静脉曲张溃疡,在四周后的消脱效力和十二周后的愈合结果。背景:专家意见表明,麦卢卡蜂蜜作为除臭剂是有效的,但尚无以随机对照试验形式提供的临床证据。很少有研究在静脉溃疡中使用麦卢卡蜂蜜。设计:前瞻性,多中心,开放标签的随机对照试验。方法:通过远程电话进行随机分组。从血管中心,急诊和社区护理医院以及腿溃疡诊所招募了一百零八名伤口静脉曲张溃疡患者,其伤口面积大于或等于50%,且未接受抗生素或免疫抑制剂治疗。与IntraSite Gel对照相比,确定了WoundCare 18+在四周后清除伤口创面的功效及其在12周后对愈合的影响。结果为:每周治疗4周,并在第12周进行随访。结果:在第4周,平均脱落率降低为67%WoundCare 18+与52.9%IntraSite Gel(p = 0.054)。泥沼覆盖的平均伤口面积分别减少到29%和43%(p = 0.065)。伤口大小的中位数减少是34%比13%(p = 0.001)。在第12周时,44愈的比例分别为44%和33%(p = 0.037)。蜕皮减少> 50%的伤口在第12周有更大的愈合机会(95%置信区间1.12、9.7;风险比3.3; p = 0.029)。 WoundCare 18+组中有6个感染,而IntraSite Gel组中有12个感染。结论:WoundCare 18+组与对照组相比,治愈率增加,有效脱落和感染发生率降低。麦卢卡蜂蜜具有治疗价值,需要进一步研究以检查其在其他伤口病因学中的用途。与临床实践的关系:这项研究证实,临床医生可以考虑将麦卢卡蜂蜜用于皮下性静脉溃疡。此外,有效的除淤显着改善了治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号